Fourth Mayo Clinic and Karolinska Institutet Joint Cancer Research Symposium
Time and date: June 22, 2023, 8:00–11:30 US CT / 3:00–6:30 CET
Location: Online via Zoom
Collaboration between Karolinska Institutet and Mayo Clinic.
Photo: KI
Registration link
Programme
8:00-8:05 CT / 3:00-3:05 CET- Welcome
Matthew P. Goetz, M.D. and Jonas Bergh, M.D.
8:05–8:15 CT / 3:05–3:15 CET- Introductory Remarks
Cheryl L. Willman, M.D., Mayo Clinic Professor of Pathology and Medicine Executive Director, Mayo Clinic Cancer Programs Director, Mayo Clinic Cancer Center and Annika Östman Wernerson, Professor of Renal and Transplantation Science, President, Karolinska Institutet
8:15–8:45 CT / 3:15–3:45 CET - Artificial intelligence image-based model development and validation for long-term breast cancer risk assessment in Swedish and U.S. screening setting
Celine Vachon, Ph.D., and Mikael Eriksson, Ph.D.
8:45–9:15 CT / 3:45–4:15 CET - Mutant p53 as a target to improve response to immune checkpoint blockade
Keith Knutson, Ph.D., and Galina Selivanova, Ph.D.
9:15–9:30 CT / 4:15–4:30 CET- Break
9:30–10:00 CT / 4:30–5:00 CET - Pseudo-Mutant p53: a Predictor of Leukemic Transformation in Clonal Hematopoiesis
Mrinal Patnaik, M.B.B.S., and Klas Wiman, Ph.D.
10:00–10:30 CT / 5:00–5:30 CET - Multi-Omics Studies of BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia
Neil Kay, M.D., and Richard Rosenquist, M.D., Ph.D.
10:30–11:00 CT / 5:30–6:00 CET- Development of targeted immunotherapy for malignant B cell lymphomas
Zhi Zhang Yang, M.D., and Qiang Pan-Hammarström, M.D., Ph.D.
11:00–11:15 CT / 6:00–6:15 CET- Closing Remarks
Matthew P. Goetz, M.D. and Jonas Bergh, M.D.